text:
Falling Down – Ein ganz normaler Tag ist ein US-amerikanischer Spielfilm aus dem Jahr 1993. Der Regisseur war Joel Schumacher, das Drehbuch schrieb Ebbe Roe Smith. Die Hauptrollen spielten Michael Douglas und Robert Duvall.

Die Handlung des Films folgt der frustrierten Hauptfigur William Foster, bekannt als D-Fens (englisches Wortspiel mit "defense", "Verteidigung"), auf seinem zunehmend von Gewalt begleiteten Fußmarsch durch Los Angeles zur Geburtstagsparty seiner Tochter, während er immer wieder in Vorfälle verwickelt wird, die ihm die sozialen Probleme der Gesellschaft vor Augen führen. Foster, der bisher ein angepasstes, bürgerliches Leben geführt hat, agiert dabei immer zorniger und gewalttätiger, und die Situation eskaliert.

Handlung
Der Kriminalpolizist Sergeant Martin Prendergast steht unmittelbar vor seiner frühzeitigen Pensionierung – es ist sein letzter Arbeitstag. Sein Vorgesetzter Captain Yardley versucht halbherzig, ihn zu überreden, länger beim LAPD zu bleiben. Prendergast betont, mit seiner Pensionierung den Wunsch seiner kranken Frau nach mehr Ruhe erfüllen zu wollen. Yardley mag Prendergast nicht besonders, bezeichnet ihn zwar als guten Polizisten, ist jedoch nur oberflächlich mit seinen Familienverhältnissen vertraut, und auch seine Überredungsversuche unternimmt er nur, weil man das laut Vorschrift von ihm erwartet.

Prendergast wird an seinem letzten Tag nur noch mit einem scheinbar unbedeutenden Fall von Nötigung in einem koreanischen Lebensmittelgeschäft betraut, der ihn jedoch stutzig macht, weil der Täter den Laden zwar mit einem Baseballschläger demolierte, aber für eine Dose Coca-Cola immerhin den – von ihm selbst festgesetzten – Kaufpreis "von 1965" zahlte. Den ursprünglich zur Selbstverteidigung des Ladeninhabers dienenden Baseballschläger nahm der Täter mit. Wenig später passt die vom Ladenbesitzer abgegebene Beschreibung des Mannes auf eine in mehrere Vorfälle quer durch die Stadt verwickelte verdächtige Person. Prendergast stellt fest, dass derselbe Mann wenige Stunden zuvor sein Auto mitten in einem Stau stehengelassen hat. Er ermittelt weiter, lediglich seine Kollegin Sandra Torres hilft ihm bei der Arbeit.

Der Besitzer des stehengelassenen Autos des Modells Chevette mit dem Wunschkennzeichen "D-Fens", William Foster, arbeitete bei einer Rüstungsfirma und wurde etwa einen Monat zuvor plötzlich entlassen. Er lebt getrennt von seiner Exfrau Elizabeth, die ein gerichtliches Kontaktverbot erwirkt hat, ist jedoch trotzdem auf dem Weg zu ihr und der gemeinsamen Tochter, um dem Kind ein Geburtstagsgeschenk zu überreichen. In einem Problemviertel gerät Foster in Streit mit zwei Mitgliedern einer Latino-Jugendgang: Er schlägt die jungen Männer, die ihn aus ihrem Revier verweisen und ihm den Aktenkoffer abnehmen wollen, überraschend mit dem Baseballschläger in die Flucht. Beide fliehen und wollen Foster wenig später aus einem Auto erschießen, haben dabei jedoch einen Unfall und werden schwer verletzt. Foster nimmt ihnen eine Maschinenpistole und eine Sporttasche mit weiteren Waffen ab, schießt einem der Jugendlichen ins Bein und marschiert weiter durch die Stadt.

In einem Fast-Food-Restaurant möchte er ein Frühstück bestellen. Da die Frühstückszeit aber seit wenigen Minuten vorbei ist und nun ausnahmslos die Mittagskarte gilt, zwingt er den sturen Filialleiter mit der Maschinenpistole dazu, ihn trotzdem zu bedienen, und feuert versehentlich einige Schüsse in die Decke. Auf dem Weg versucht Foster wiederholt, seine Exfrau telefonisch zu erreichen. Bei einem neuen Anrufversuch ist die Telefonzelle lange besetzt. Foster gerät in Wut über einen sich beschwerenden Passanten, der ebenfalls telefonieren will, und zerstört die Telefonzelle mit einem Feuerstoß aus seiner Maschinenpistole. Als er in einem Militarialaden Wanderstiefel kaufen möchte, wird er vom Ladeninhaber vor Officer Torres von der Polizei versteckt, obwohl diese sich mit einer treffenden Personenbeschreibung bei ihm nach Foster erkundigt. Der Händler deckt ihn, weil er den Polizeifunk abgehört hat und im Bilde ist. Er glaubt irrtümlich, dass die beiden dieselben faschistoiden Neigungen, insbesondere gegenüber diversen Minderheiten wie Homosexuellen und Schwarzen, teilen. Als klar wird, dass das nicht so ist, versucht der Ladeninhaber, Foster Handschellen anzulegen, um ihn der Polizei zu übergeben. Foster wehrt sich jedoch mit dem Butterflymesser, das er einem der Latinos beim ersten Zusammentreffen abgenommen hat und erschießt den wehrlosen Mann. Aus dem Laden ruft er seine Exfrau an und teilt ihr mit, dass er sich nun auf einem Weg ohne Rückkehrmöglichkeit befinde – ähnlich einer Raumschiffbesatzung mit abgerissenem Erdkontakt. Sie ist nun alarmiert. Als man ihn auf seinem weiteren Weg – Foster ist nun in Militärkluft – an einer seiner Meinung nach unnötigen Straßenbaustelle nicht durchlassen will, jagt Foster die Baustelle kurzerhand mit einer M72-Panzerabwehrwaffe, die er ebenfalls aus dem Militärladen mitgenommen hat, in die Luft. Er kreuzt den Golfplatz eines feinen Countryclubs, ruft dort den Herzanfall eines erschreckten Mitglieds hervor und bricht in ein Villengrundstück ein.

Prendergast versucht seine Arbeitskollegen derweil davon zu überzeugen, dass es sich bei den Vorfällen um ein und denselben hochgefährlichen Täter handelt. Sie nehmen seine Vermutungen jedoch nicht ernst, vielmehr schickt ihn sein unmittelbarer Vorgesetzter an seinen Schreibtisch zurück und eröffnet ihm, dass er ihn in Wahrheit nie ausstehen konnte. Seiner Meinung nach drückt sich Prendergast seit Jahren vor dem Dienst auf der Straße und ist damit in seinen Augen kein richtiger Polizist. Auf eigene Faust weiter ermittelnd kommt Prendergast dahinter, dass Foster auf dem Weg zu seiner Exfrau und seiner Tochter ist. Kurz bevor Foster das Haus erreicht, kann sich Elizabeth mit der Tochter aus dem Haus schleichen. Er schaut sich daraufhin ein paar alte Videobänder an und schwelgt in Erinnerungen, wobei er auf den möglichen Fluchtort der beiden kommt – einen Pier in Venice Beach in der Nähe ihres Hauses.

Als Foster von den eintreffenden Beamten Prendergast und Torres überrascht wird, verletzt er Torres durch einen Schuss und begibt sich zum Pier, wo es zum Aufeinandertreffen mit Exfrau und Tochter kommt. Prendergast erreicht die gerade von der Polizei geräumte Seebrücke wenige Augenblicke später und schafft es durch einen Trick gemeinsam mit Fosters Exfrau, diesen zu entwaffnen, woraufhin die Frau mit der Tochter flieht. In einem kurzen Dialog will Prendergast Foster zum Aufgeben bewegen. Dieser zieht es jedoch vor, zu sterben, um so seine Tochter mithilfe seiner Lebensversicherung zu versorgen. Daher inszeniert Foster ein Schussduell "wie im Western", indem er Prendergast vorgaukelt, noch eine weitere Waffe zu tragen. Daraufhin wird er von Prendergast erschossen und fällt vom Pier in den Ozean. Dabei stellt sich die weitere Waffe als eine Wasserpistole heraus, die Foster unterwegs an sich genommen hatte, um den von ihm geplanten Suicide by cop zu provozieren. Als Captain Yardley, der Prendergast bei seinen Ermittlungen nicht unterstützt hat, vor Journalisten seinem Sergeant "ausgezeichnete Arbeit" attestiert, wird dies von Prendergast mit einem trockenen "Lecken Sie mich am Arsch, Captain!" kommentiert.

Soundtrack
Die Musik wurde von James Newton Howard komponiert.

Synchronisation
Die deutschsprachige Synchronisation entstand bei der Deutschen Synchron in Berlin.

Kritik
Der Film erhielt überwiegend positive Kritiken und erreichte bei Rotten Tomatoes eine Bewertung von 73 %, basierend auf 49 Kritiken und bei Metacritic einen Metascore von 56 %, basierend auf 21 Kritiken.

James Berardinelli bezeichnete auf ReelViews die erste Filmhälfte als "effektiv". Der emotional labile William (Bill) Foster stehe dem emotional gefestigten Martin Prendergast gegenüber. Berardinelli schrieb weiter, der Film sei voller Galgenhumor, sodass man ihn fast als schwarze Komödie klassifizieren könne. Eine der schockierendsten Szenen des Films sei nach Meinung des Kritikers jene, in der ein junges Kind Bill zeige, wie man einen Granatenwerfer benutzt.

Cinema nannte den Film ein "böses Psychodrama", eine "schonungslose, schwarze Satire auf den Normalbürger" und zog das Fazit: "Das definitive Ende des amerikanischen Traums".

Die Filmbewertungsstelle Wiesbaden verlieh der Produktion das Prädikat "wertvoll".

Auszeichnungen
Ebbe Roe Smith gewann für das Drehbuch den Edgar Allan Poe Award. Der Film wurde 1993 für die Goldene Palme nominiert; Andrzej Bartkowiak wurde für seine Kameraarbeit für einen Preis des International Film Festival of the Art of Cinematography in Łódź in Polen nominiert.

Musikkulturelle Bezüge
Im Jahr 2011 benutzte die amerikanische Rockband Foo Fighters den Film als Vorlage für das Musikvideo zu ihrer Single Walk.
Das Lied Man on the Edge der Band Iron Maiden vom 1995 erschienenen Album The X Factor handelt von dem Film.
Der deutsche Rapper Blokkmonsta nahm bezug auf den Film in einem gleichnamigen Song.

Weblinks

Einzelnachweise

Filmtitel 1993
US-amerikanischer Film
Filmdrama
Thriller
Joel Schumacher


text:
Mary Beth Fisher and Jefferson Mays in "Dear Elizabeth" at Yale Repertory Theatre in 2012. (Photo by Joan Marcus)
Seasons August 25, 2015 American Theatre Editors	Leave a comment
Women's Project Theater Announces New Season in a New Home
On the slate are Sarah Ruhl's epistolary play about Elizabeth Bishop and Robert Lowell, and a coproduction with Rattlestick of Martyna Majok's 'Ironbound.'
NEW YORK CITY: Women's Project Theater announced their 2015–16 season of plays, which will run in their new Upper West Side home at the McGinn/Cazale Theater. Producing artistic director Lisa McNulty and managing director Maureen Moynihan announced the beginning of a three-year residency at the theatre on Broadway at 76th Street.
"I'm thrilled for WP Theater to set down roots in this wonderful space with such a storied theatrical history, and to bring all of these brilliant women together in one season," said McNulty in a statement. "This is the essence of what WP Theater does—create a theatrical home where female-identified artists are welcome at every point in their careers, a place where women's voices are central."
The season will begin with the New York premiere of Sarah Ruhl's play Dear Elizabeth (Oct. 26–Dec. 5). The play, which will feature a rotating cast, examines the relationship between the poets Elizabeth Bishop and Robert Lowell through letters they wrote to each other.
Rattlestick Playwrights Theater and WP will then partner to present Ironbound by Martyna Majok (March 2–April 10), in its New York premiere. The play follows a woman for whom love is luxury.
Closing the season will be the first WP Pipeline Festival, running March 24–April 23. The festival will feature five new plays developed during the WP Lab's two-year residency. The artists involved are Sarah Burgess, Money Hurst-Mendoza, Martyna Majok, Riti Sachdeva, Susan Soon-He Stanton, Adrienne Campbell-Holt, Lee Sunday Evans, Sarah Krohn, Danya Taymor, Tamilla Woodard, Rachel Karpf Reidy, Pearl Kermani, Kristen Luciani, Liz Olson, and Rachel Sussman.
WP Theater will also produce a series of events with other gender-focused theatre and advocacy groups, including the Kilroys and the Lilly Awards. Details of these events are yet to be announced.
Sarah RuhlThe KilroysThe Lilly AwardsWomen's Project Theater
Previous PostPegasus Theatre Season to Include Nambi E. Kelley World PremiereNext PostWhat Will We Miss About Center Stage's Peter Culman? Curiosity, Grace, and a Cup of Tea

redpajama_set_name: RedPajamaCommonCrawl


text:
AIS Foundation
About AISF
AIS Online Library
AIS Library
The AIS
We would like to encourage anyone who has an idea for research or education about irises that fits within the broad goals to submit a proposal for funding. The Foundation typically can invest up to $20,000 per year in projects that support its goals.
It is important to note that the Foundation will, except in extraordinary circumstances, invest only the interest from its endowments in support of its goals. The Foundation intend to maintain the principal of these endowments as a perpetual source of support for its activities.
Proposals should clearly describe the objectives and significance of the work to be supported, provide enough detail of the methods and approaches to allow assessment of its feasibility, outline the time-frame for its completion, and describe how it is expected to forward the goals of the Foundation. Where appropriate, a curriculum vitae or other evidence of the capabilities of the applicant to conduct the work should be provided.
It is expected that a report on the use of the funds will be submitted to the Foundation upon completion of the project and that significant scientific findings will be published in a timely fashion. Part of the award may be withheld until reports and/or manuscripts are received by the Foundation. Prior discussion with one of the Foundation Officers regarding the suitability of the concept and proposed funding level is encouraged.
Proposals may be submitted to the President at any time.
Examples of projects funded by AISF over many topics relevant to the genus iris -- including iris genetics, taxonomy, the collection of new species and iris cultivars including the control of pathogens and other pests. Over the years, grants have been issued to top researchers and educational institutions throughout the United States as well as internationally. AISF supports the AIS Library through the Evelyn Jones Memorial Library Fund. The Foundation also funds the Ackerman Youth Essay contest.
Bob Hollingworth
124 Sherwood Rd. E.
Williamston, MI 48895
AIS Foundation © 2023. All Rights Reserved.


text:
Djursholm (pronúncia /jʉʂˈhɔlm/;  ouça a pronúncia) é um bairro do município de Danderyd, a norte da cidade de Estocolmo.
Pertence ao condado de Estocolmo, e tem uma população de  habitantes.

Foi fundado em 1889, como o primeiro "bairro residencial de moradias da alta burguesia intelectual" (villasamhälle), e foi elevado a cidade em 1914.

Personalidade ligadas a Djursholm
Elsa Beskow, escritora e ilustradora de contos infantis
Jan Carlzon, dirigente empresário
Verner von Heidenstam, escritor
Viktor Rydberg, escritor
Alice Tegnér, compositora
Björn Ulvaeus, músico
Marie Fredriksson, cantora
Charlotte Perrelli, cantora
ToveLo, cantora

Ligações externas
Página de Danderyd

Localidades de Estocolmo (condado)
Localidades da Uplândia

redpajama_set_name: RedPajamaWikipedia


text:
Buzz Report
Beehind The Buzz
PCG Investor Alert: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of PG&E CorporationInvestors
Posted on 06/15/2018 55
Law Offices of Howard G. Smith announces that a class action lawsuit has
been filed on behalf of investors that purchased PG&E Corporation ("PG&E"
or the "Company") (NYSE: PCG)
securities between April 29, 2015, and June 8, 2018, inclusive
(the "Class Period"). PG&E investors have until August 13,
2018 to file a lead plaintiff motion.
Investors that suffered losses on their PG&E investments are encouraged
to contact the Law Offices of Howard G. Smith to discuss their legal
rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.
On June 8, 2018, the California Department of Forestry and Fire
Protection announced that its investigators determined that 12 Northern
California wildfires that occurred in late 2017 were caused by PG&E
equipment. On this news, PG&E's share price fell more than 4% on June
11, 2018, thereby injuring investors.
The complaint filed in this class action alleges that throughout the
Class Period defendants made false and/or misleading statements and/or
failed to disclose that (i) PG&E had failed to maintain electricity
transmission and distribution networks in compliance with safety
requirements and regulations promulgated under state law; (ii)
consequently, PG&E was in violation of state law regulation; (iii)
PG&E's electricity networks would cause numerous wildfires in
California; and (iv) as a result of the foregoing, Defendants'
statements about the Company's business and operations were materially
false and misleading at all relevant times.
If you purchased shares of PG&E during the Class Period, have
information or would like to learn more about these claims, or have any
questions concerning this announcement or your rights or interests with
respect to these matters, please contact Howard G. Smith, Esquire, of
Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem,
Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888)
638-4847, or by email to howardsmith@howardsmithlaw.com,
or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
Global Atlantic Financial Group Joins Alliance for Lifetime Income, Focused on Protecting Americans Finances in Retirement
MOH Investor Alert: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Molina Healthcare, Inc. Investors
The Market Buzz
"Buzz on the Street" Show: Plurilock Security (OTC: PLCKF) (TSX-V: PLUR) Agreement with X10 Networks
Breaking News: Plurilock Announces Reseller Agreement with X10 Networks
Breaking News: PlantX Announces Partnership with Cosmetic Brand Nootka & Sea
Exxon Under Investigation by the SEC Over Asset Valuation
Walmart's E-Commerce Chief Marc Lore to Retire
The Buzz Surrounding First Responder Technologies Inc.
Entertainment One and Alibaba Pictures Announce Joint Production to Bring Peppa Pig to Theaters in China
Environmental Class Action Plaintiffs Achieve Major Victory in Federal Appeals Court


is the number of decimal digits in 9 GB. 9*(10^9)*8 is the number of bits in 9 GB, and log(2)/log(10) is the factor to convert into the number of decimal digits (look up how to perform base changes when using logarithms). This is about Nd = 21.7 billion decimal digits.... Your solution will let me export the icq-numbers of my contacts. I was however looking for a solution more along the lines of what shuboarder has given above. I was however looking for a solution more along the lines of what shuboarder has given above.
23/10/2003 · But I am serious about this. The 1st thing DNX made me do when I was apart of that clan was to get an ICQ number. Instant messaging is how we talk to each other.
ICQ Password. ICQ Password is a password recovery tool for ICQ. Whenever you lose or forget your password for ICQ, make a couple of clicks and you will get a list of all ICQ users on the computer.
13.3.1 How to get the iQN code With the iSCSI ( internet Small Computer Systems Interface ) protocol you are required to use an alphanumeric code called iQN ( iSCSI Qualified Name ) so that the client (Cloud Server) can communicate with the target (Unified Storage).


text:
From January 28-February 3, 2018, we will celebrate Catholic Schools Week – an annual celebration of Catholic education in the United States. Catholic schools in the Diocese of Orlando provide top-notch academics, but it is the faith element and community that sets them apart. Around the Diocese of Orlando, schools will celebrate with Masses, open houses and … Continue reading "Celebrating Catholic Schools Week (Jan. 28 – Feb. 3)"
Bishop Noonan reflects on the Joy of the Gospel in our Catholic Schools
"A great prophet has arisen in our midst and God has visited his people." Luke 7:16 My Sisters and Brothers in Christ: God has visited His people. What a joyous proclamation! This joy of the Gospel is the breath of the Holy Spirit within our heart. Pope Francis said, "The joy of the Gospel fills … Continue reading "Bishop Noonan reflects on the Joy of the Gospel in our Catholic Schools"
Come and See – a retreat for Catholic women 18+
Enjoy a retreat filled with peace and prayerfulness in the company of the God who loves you! Join other women in discernment for a day of prayer, good food and input from Religious Sisters about their own discovery of God, the true Love of their lives. It is a wonderful opportunity to listen to and … Continue reading "Come and See – a retreat for Catholic women 18+"
Celebrate love at the Mass for Marriage on February 10
Couples are invited to renew your Wedding Vows and bless your love at the Mass for Marriage! Friends and families are also invited to join the celebration. This year to help commemorate the 50th Anniversary of the Diocese, the Mass will be celebrated at the Basilica of the National Shrine of Mary, Queen of the … Continue reading "Celebrate love at the Mass for Marriage on February 10"
New president heads Catholic Foundation of Central Florida, Inc.
Bishop John Noonan announces the appointment of Kimberlee Riley as the President of The Catholic Foundation of Central Florida, Inc., effective February 5, 2018. Ms. Riley will replace Meghan Post who served the Foundation for nearly five years as its President. As President of The Catholic Foundation of Central Florida, Inc., Ms. Riley will lead … Continue reading "New president heads Catholic Foundation of Central Florida, Inc."
Viera parish celebrates dedication
The dedication of St. John the Evangelist Church and altar in Viera Jan. 20 was perfectly planned and precisely orchestrated; all progressed with the dignity and joy of such a momentous occasion. Bishop John Noonan pronounced the final blessing, Holy Cross Father John Britto Antony, parochial vicar invited everyone to the reception and then an … Continue reading "Viera parish celebrates dedication"
Human Trafficking Symposium empowers residents to become proactive
Katariina Rosenblatt was 13 years old when she experienced her first brush with sex trafficking in South Florida. She met a 19-year-old girl, who lured her into a false sense of friendship and tried to sell her to a 65-year-old man for $550. She attributed escaping her first encounter through the grace of God, but … Continue reading "Human Trafficking Symposium empowers residents to become proactive"
Urge support for religious freedom
Background The Constitutional Revision Commission (CRC) convenes once every 20 years to examine the Florida Constitution and propose changes for voter consideration. Committees of the Florida CRC are currently discussing several proposals. One proposal in particular that is being consider is Proposal 4 by CRC Commissioner Roberto Martinez. This proposal would remove Florida's Blaine amendment from the … Continue reading "Urge support for religious freedom"
Healing Christ's Church
One look at the news and it is enough to dash our hopes for unification among Christian faiths, let alone a united humanity. A Prayer Service for Christian Unity at San Pedro Spiritual Development Center in Winter Park on Jan. 23 set out to take one step toward defying the odds. Together with Bishop John … Continue reading "Healing Christ's Church"
Prayer Vigil for the Unborn
More than 80 people gathered on the steps of the Volusia County Courthouse on Jan. 22, the anniversary of the Supreme Court ruling on Roe v. Wade, to pray for the unborn and for a reversal of the devastating decision which has ended the lives of an estimated 58 million babies due to abortion since … Continue reading "Prayer Vigil for the Unborn"
Bishop Noonan reflects on speaking and living the Word of God
I will raise up for them a prophet like you from among their kin, and will put my words into his mouth; he shall tell them all that I command him. Deuteronomy 18:18 My Sisters and Brothers in Christ: Prophet? Who me? No way! Is that how you would characterize your reaction to God's Word … Continue reading "Bishop Noonan reflects on speaking and living the Word of God"
The secret to a happy marriage: what newlyweds and seasoned marriages have in common
The fact that fewer couples are committing to marriage is not news. In fact, Pew Research indicates only half the adults in the U.S. are married—mostly because couples are opting to live with their partners and raise children outside of the marital covenant. In the secular world, marriage is almost frowned upon, so that marriage … Continue reading "The secret to a happy marriage: what newlyweds and seasoned marriages have in common"
Catholic Brothers Bring Gifts to Bahamas
What began as a fun family vacation to the beautiful Exuma Islands in the Bahamas, ended up opening the eyes and hearts of two Father Lopez Catholic High School students. The experience moved them to begin a charity project that would ultimately help a needy school for years to come. Cameron, a senior at Father … Continue reading "Catholic Brothers Bring Gifts to Bahamas"
Pope's Communications Day Message: Counter "fake news" by seeking the truth
In his 2018 Message for World Communications Day (May 13, 2018), Pope Francis calls on communications professionals to be "the protectors of news" and to combat the spread of fake news though a "journalism for peace." We need a kind of journalism that is less concentrated on "the mad rush for a scoop," and more on … Continue reading "Pope's Communications Day Message: Counter "fake news" by seeking the truth"
President of U.S. Bishops Conference Response to Kentucky High School Shooting Cardinal Daniel N. DiNardo, Archbishop of Galveston-Houston and President of the U.S. Conference of Catholic Bishops, has issued the following statement on today's shootings at Marshall County High School in Benton, Kentucky. The shooting has left up to two dead and more than a … Continue reading "USCCB News"
Agriculturist turned pastoral scholar part IV
Catholic Rural Life guest blogger, Duane Short, continues his series, Agriculturist Turned Pastoral Scholar, exploring real-life examples of people who are solving major problems in agriculture. Where is the middle in agriculture that I desire? Is there a place where participants in a dilemma actually listen to each other, talk to each other, really hear … Continue reading "Agriculturist turned pastoral scholar part IV"


Is it a good idea to use an AWS server as a vpn?
I have an amazon server that I use to host my email and my simple website. I'm considering setting a vpn up on it, but I'm not sure if it's worth it. Would my data be as secure as with 3rd party vpns? Would Amazon see my traffic? It seems like if I go this route, anything that I do could be traced back to me, because the see the ip of my server and than ask amazon who owns it.
Any homeserver operators out there?
I am a long time homeserver operator and was just wondering if there was anyone else around that is into server hosting and system administration like me.
if you do, feel free to share any stories you may have about being a homeserver operator.


Are you facing issues where your Roku player is not able to update or download the latest software? If yes, please read this article further to help your player get past this Roku error code 005! Post Roku link account , it is common to find few Roku error codes! Being a new Roku user, it is important to understand the possible types of Roku Error Codes (Roku error Code 005) that may pop up.
Checking if your Roku device has a good network connection is the first step to stay away from these Roku error codes.
If you find this connection to be unreliable, or if an unexpected outage exists, the streaming may be unable to update to the latest software.
You might see error codes displayed on the screen like the Roku Error Code 005.
Solving Roku Error Code 005 is pretty easy, as it is a simple connection failure which has yield to such error popping up.
Check if you have connected to your Roku device and to the correct network.
The wrong wireless network name connection will cause your wireless network connection to fail. Confirm the network and password details.
A router check is mandatory to see if it is working properly.
Use another computer or a mobile device to connect to the router which can tell you if it is working properly.
Check on the strength of the wireless signal.
If it's not strong enough, a software update will fail.
The further your Roku device is placed from your router; the signal will become weaker.
There are also obstacles like walls and cabinets which come between your router and your Roku device and which have to be taken into account.
If your network credentials are right, and the software update still continues to fail, the strength of the wireless signal could be the possible reason.
For router restart, check the instructions from your internet Service Provider (ISP) or router vendor.
The device automatically connects, if there has been a previous connection.
It is equally important to understand the other possible types of Roku Error Codes (Roku error 005) that may pop up like Roku Error code 014, Roku Error code 009, Roku Error code 001, Roku Error code 011 and Roku Error code 003.
Stay tuned to understand more articles on how to troubleshoot Roku error Codes. Reach out to us +1-888-269-1011 , for personalized guidance on Roku Error code 005. For more updates visit us https://www.go-roku.com we will also help you to create Roku link account.


Eclipse is an integrated development environment (IDE). It is written primarily in Java and can be used to develop applications in Java and, by means of the various plug-ins, in other languages as well, including C, C++, COBOL, Python, Perl, PHP, and others.
Download Eclipse IDE for Java Developers from http://www.eclipse.org/downloads/. We will be using version 3.6, release "Helios".
On your C: drive, create a folder called "Programs". We will be using this folder also for Processing and Arduino. So please do so.
Open the Zip file you just downloaded, extract the "eclipse" into "C:\Programs". ( NOTE, not "C:\Program files").
In "C:\Programs\eclipse\", you should be able to find "eclipse.exe". Otherwise check carefully the previous steps.
Create a shortcut to "eclipse.exe" on your desktop.
Then you will be asked where you would like to store your projects. Any folder would do, but I would suggest to create a "workspace" folder in your "Documents" or "My Documents". No matter where it is, remember it.
After that you should be welcomed by Eclipse. Click on the icon "Workbench" at the right, we will be ready for the business.


Propaganda Illuminati has been added to your cart!
The age of enlightenment is here! We are proud to present you with this delicious assortment of blood orange, pineapple and strawberry. With Illuminati, you won't know what hit your taste buds!


text:
Ajara is a census town and the taluka headquarters of Ajara taluka in Kolhapur district in the state of Maharashtra, India.

Geography
Ajara is located at . It has an average elevation of .

It is known for its scenic and green landscape, as well as for its Ajara Ghansaal rice.

Ajara is 84 km from Kolhapur and 33 km from Amboli Hill station. The nearest major city is Gadhinglaj.

Demographics
, Ajara had a population of 18,000. Males constitute 51% of the population and females 49%. Ajara has an average literacy rate of 75%, higher than the national average of 59.5%; with 55% of males and 45% of females literate. 12% of the population is under 6 years of age. Marathi is predominantly spoken.

Places To Visit
Places such as Ramtirth waterfall, a lord Rama temple on the Hiranyakeshi river and Ravalnath temple are located nearby.

See also
Pedrewadi
Haloli

References

Cities and towns in Kolhapur district
Talukas in Maharashtra


Functional and attractive luggage tags available on Brown Kraft. Choose from a number of excellent designs that co-ordinate with our wrap.
Functional and attractive luggage tags available on White card (brown kraft back). Choose from a number of excellent designs that co-ordinate with our wrap.
Functional and attractive gift tags on Brown Kraft or White card. Choose from in a number of excellent designs that coordinate with our wrap.
Practical or decorative, these tags have many uses.


By offering us together with your phone quantity, you consent to be contacted by CollegeAmerica or its affiliated schools about our instructional packages. It was not till 1925 that a mainstream printing and design trade magazine, Typographische Mitteilungen, the month-to-month organ of the German Printer's Affiliation in Leipzig , shocked the professional nervous system by sanctioning the most radical of approaches.
Founded in 1985, the HOW model now extends past the print magazine to annual occasions for design professionals, yearly design competitions, digital merchandise and books. Employment of graphic designers in newspaper, periodical, ebook, and listing publishers is projected to say no 16 percent from 2012 to 2022.
Compared to the elegant austerity of the Bauhaus, Streamline was an bluntly futuristic mannerism based mostly on modern aerodynamic design born of science and expertise that included decorative prospers symbolizing velocity, in contrast to the best angles of European modernism.
Print documents and critiques business, social, and environmental design from each angle: the good (how New York's public-faculty libraries are being reinvented by way of daring graphics), the bad (how Tylenol flubbed its disastrous advert marketing campaign for suspicious hipsters), and the ugly (how Russia relies on Soviet symbolism to promote sausage and real property).
We design the best logo to establish your presence within the network fraternity. From on-line advertising and marketing to promotional merchandise to enterprise checks , our full suite of services and products are time-examined by companies like yours. Whether or not you begin with a template or work with our design crew on a brand new creation, every brand marries great style with exceptional design. For tutorials on easy methods to create logos, the inventive elements of brand design, see Ideas, Tutorials on How one can Design Logos below.
With online Paint tool you'll discover many painting instruments that you must unlock new artistic potentialities. One interesting facet of emblem design that I've been contemplating rather a lot these days is the idea of instilling motion or a sense of exercise into a logo. Devoted tool to precisely pick colour, whether over your design or from every other window in your display. Once you save your design you will at all times in a position to get entry and edit/customise/modify it again, many times. This lets you view vectors in each standard and retina resolution, providing you with a totally reside view of how every ingredient of your design will export. Therefore, the design of logos and their incorporation in a visible id system is likely one of the most troublesome and necessary areas of graphic design. After spending approach too many hours making an attempt to design my brand, I stumbled throughout Logojoy and it saved the day!
Whereas we're as regards to being distinctive, there's virtually nothing that may give your logo a unique really feel quite like some awesome custom lettering. Thanks for the publish, Its detailed and you have talked about some actually good level on emblem designing.
Those were not an precise logo but merely as a picture or a symbol that may be interpreted as a one of the most primitive communication system. Though graphic design is primarily completed on computers these days, it is generally good to get again to your roots and draw out your concepts by hand with an excellent old style pencil and paper. More than 10.000 design parts are ready-to-use for customize logo design templates or to create a brand design from scratch. The next listing accommodates Internet sites or sections of Web sites whose functions are to offer ideas, tutorials, articles, assets and other data associated particularly to emblem design. But in the long run it is going to reward you nicely as a result of this logo might be your identification to the world.
I just get so irritated with local designers producing designs that they want you to use. We've noticed you're using an unsupported model of Web Explorer, please obtain one of many following browsers for the perfect experience. In any case, the whole point of a letterhead is to hold the contents of a letter, so that you must be sure that there's space for it.
Test printing on the paper and print in colour to get a really feel for a way your advertising supplies will look with it. You are able to do this with one of many free letterhead templates on this web page or with a custom-made business letterhead template that you've created with your own design elements.
Only Kool Design Maker has the ability to give your custom letterhead design a small advertising and advertising touch, so you can receive a very good exposure and a focus from your small business clients. Designhill is a graphic design platform for designers to earn, participate, work and share their work and is a one point cease for enterprise owners to source prime quality designs together with logos, website design and more at inexpensive prices. When used cohesively with different merchandise, your letterhead gives you the chance to put your online business name, logo, company colours, and call information as proven in many of the samples below.
I gave them nothing to get inspiration from, only a imprecise idea of what I had in my head and they delivered past my expectations. So if you wish to create your own but need a little inspiration, we have chosen thirteen stunning examples of letterhead designs that will help you stand out from the group. I'm really excited to show off my bakery letterhead that was created work that I can actually be proud of. Canva will save a duplicate of your design on your homepage so you can go back and edit it any time.


text:
Home Lung Cancer Living With Lung Cancer
Lung Cancer Trials in the Time of the Coronavirus Crisis
Read Transcript
Racial Health Disparities Persist in Lung Cancer Treatment
Lung Cancer Patient Story: Finding Hope and Taking Action
How Can KRAS Patients Get Involved and Learn More?
At many institutions, therapeutic clinical trials are continuing to run.
Trials are helping patients protect themselves by avoiding unnecessary blood draws, using telehealth and shipping oral medicines directly.
For patients requiring in-person visits, clinics have created barriers to enable social distancing and to minimize risk.
"Cancer is not going to take a timeout during COVID-19 and neither can we," says leading expert Dr. Sandip Patel, from UC San Diego Health's Moores Cancer Center.
How is the outbreak impacting lung cancer clinical trials, which represent the best treatment opportunities for some patients? Here, Dr. Patel describes the state of lung cancer care and availability of medical resources with the surge of coronavirus cases.
Dr. Patel also explains the concept of gaining herd immunity without overwhelming the healthcare system. Watch now to learn from an expert.
Sandip Patel, MD
Andrew Schorr
Transcript | Lung Cancer Trials in the Time of the Coronavirus Crisis
Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That's how you'll get care that's most appropriate for you.
Andrew Schorr:
Hello from Carlsbad, California in Southern California, north of San Diego. I'm Andrew Schorr, and we're joined today for this lung cancer live webinar with a noted expert in lung cancer from where I get care actually as a cancer patient. That's the Moores Cancer Center at the University of California, San Diego. Dr Sandip Patel. Dr. Patel, thanks for joining us. Tell us your titles there because you've got a bunch of them, and we're going to be talking about research also related to lung cancer and I know that's a key interest of yours.
Dr. Patel:
Thanks so much. I'm an associate professor here at UC San Diego. I'm the co-leader of external therapeutics and the director of the clinical trials office and so very eager and enthusiastic to talk to you about how the current time with COVID-19 has affected our patients and what our patients can do here and nationally to deal with yet another crisis on top of everything they're having to deal with already.
Right. You said it. Anybody, and I'm living with two blood-related cancers, we have that anxiety going on all the time. And now in the age of lung cancer where fortunately more people are living longer based on research you and your peers have been involved in around the world, in patients participating in trials, you have that anxiety that said, "Oh no, now how does this virus put me at risk or risk of complications because of my lung cancer history?" So let's talk about that for a minute. So, many people are living longer, not enough, and we still have a ways to go for sure.
But immunotherapy, targeted therapies, combination therapies, et cetera, have helped a lot of people. And so now you have people, some people rather than living six months, living 10 years. And I know people like that. And maybe they participated in trials. Where are we with trials now when we have this overlay of the virus? And some people may have traveled at a distance to get to you in San Diego for trials you're doing. And that's not convenient to say the least.
Absolutely. So two great questions. I think one, the overarching theme that we've really moved the needle in cancer. And cancer survival has actually improved across the board in the United States. The single greatest improvement in cancer survival actually took place in the past year. And much of that is actually driven by improvements in the care of lung cancer patients. And more interestingly, the current survival data doesn't even fully capture the improved survival we have due to immunotherapies that are currently both in clinical trials for new immunotherapies but also widely available in the stage III and stage IV settings for non-small cell lung cancer, small cell lung cancer and increasingly other thoracic malignancies. And so the point that we've really been able to bend a curve as you talk about COVID-19 but also improve survival and bend that curve in a good direction in terms of survivors for lung cancer to the point that it's affecting the overall numbers of cancer survival throughout the U.S. in a positive way can't really be understated.
And I think we're going to continue to see some improvements here as well. And that's because of as you described, the great effort that really patients I think who trust us with their care and in the context of their cancer with clinical trials that are designed to maximize their potential benefit. And so therapeutic clinical trials represent an opportunity for patients who may otherwise lack available standard of care options. So that clinical trial represents a therapeutic option for that patient. And so what we've done at UCSD and many institutions have, though it's not universal, is all our therapeutic clinical trials are continuing to run.
And for those that involve pills, we're actually trying to set up a way of having those shipped directly to the patient, and avoiding some of these unnecessary blood draws and visits doing many things by telemedicine, just like we're doing this by televisit right now by video visits, and seeing if sponsors and the FDA allow, increasingly they do. And for infusions, we're trying to make sure that patients remain safe. They're socially distanced from other patients, they have barriers between themselves and others. And that they're masked when they're here so that they minimize their risk. And so cancer is not going to take a timeout during COVID-19 and neither can we. And we believe therapeutic clinical trials for many of our patients represent some of their best opportunities. And many of these have actually become the therapies that have improved survival that we talked about earlier.
Now obviously the time of the virus is in overlay, we were going to have another lung specialist and researcher on with us, Thomas Marin from Mount Sinai in New York, the biggest hot spot right now as we do this program on April 8th. And he couldn't make it, because he's called all over the hospital to help with patients. And I'm sure some of them are lung patients who develop COVID. So let's talk about that. We got questions in, and if you have a question in our audience just at the Q&A button at the bottom of your screen if you haven't already sent in a question. Are lung cancer patients more likely based on having in-treatment or having had treatment for lung cancer to be more at risk of complications from the virus? What do we know? Do we know anything now?
It's a great question. We do know patients with cancer and pre-existing lung disease have heightened risk of COVID-19, and so having lung cancer is the intersect of those two. And so the same things we do in our daily life I think in terms of social distancing are even more important for patients in particular with lung cancer, but cancer more broadly as well.
Okay. So, we know that the virus goes to your lungs, and I know it's kind of operating differently than a tumor that may be sited in your lungs. So having had tumors in your lungs then doesn't necessarily mean that let's say you had a—or having had a lung removed for example, does that mean you're going to have a rougher go?
It's possible. There's not a lot of clear data on this. And a lot of this is still emerging, but many of us feel that if you've had some sort of injury to the lung, whether it be cancer, whether it be prior tuberculosis for example, COPD, asthma, there's just not as much reserve in the lung capacity if one were to have a very severe COVID-19 infection. And so universally we view patients with cancer, pre-existing lung disease and the intersect of both, which is lung cancer as patients who we need to take heightened precautions with in their care during the COVID-19 pandemic.
Dr. Patel, I've got to ask you the question that a lot of patients I think have been asking you, and it's all over the Internet among lung cancer patients. So you talked at the outset that people are living longer, and you've sort of been bending the curve about survival with lung cancer, but still, people are outliving what was the textbook estimation of how long somebody with advanced lung cancer would live. So if they develop COVID and they're in a place whether it's like New York or San Diego or New Orleans or Detroit, and there's a shortage of ventilators or resources, is there something tattooed on their forehead with an expiration date, advanced lung cancer patient, they are later in line for that sort of care that they would need? What's your answer about that?
Yeah, it's a great question. I'm so glad you asked that. I've actually been asked that exact same question by my patients. And I could tell you from my own personal experience, I was just on the wards. And the way we make decisions is not based on who someone is outside of COVID-19, but where they are now in terms of their care. And there's been no rationing of ventilators here at UC San Diego or frankly even in New York from what I've heard. What they've done is they've actually repurposed sleep apnea machines, really necessity is the mother of invention. And so to my knowledge there's not been a single decision along those lines that has been made. And I don't expect those to have to be made because of our ability to adapt to the situations at hand. But one of the points I make, and this is something very true in medical ethics, is we don't judge people by these parameters, even in peacetime, let alone wartime based on where they are.
It's based on what is going on right now and what the situation is in terms of their healthcare. And are there patients who don't have cancer who may have such severe COVID-19 that continuing ventilation may not make sense? Possibly. That may also be true for cancer patients as well, but I think the key point is just because you have the diagnosis of cancer, the label of cancer in your chart or you're getting treatment, that's not some sort of stigma that you get pushed to the back of the line. But the bigger point is, right now there are no lines. And I don't see any lines developing because of all these rapid technologic innovations. One thing you may have heard about in the news is Washington and California, Washington being one of the initial places with COVID-19, we've all sent ventilators to New York.
So we're all in this together. And so New York, when they're through it, they're going to send their ventilators to whoever else needs it. And so I just want people to know that everyone's paying attention to this. We're one people. We've got this, because we're one united group of people. We're going to get through this, because we're one group of individuals. Americans are suffering with this, and we'll figure this out together, and it's a team sport. And I just don't see it going down that road. You can put two people sharing on a ventilator. There are all sorts of other things you would do before you could ever get to the point of rationing. I have not seen or heard of any rationing. I just don't expect it to happen. And even if it did, the medical history wouldn't be how those decisions would be made. It's based on how you're doing related to the COVID, not your cancer.
Right. And there could be somebody who is a stage IV lung cancer patient, and I have friends like this who are doing pretty well based on the therapies that have been developed, experimental or approved. Okay, Dr. Patel, let's just recap one thing about research. What you were saying at the outset is, the lung cancer research is continuing. What you're doing is continuing, and you're relaxing some of the requirements with the permission of the FDA and sponsors where you can. Okay. So that's great news, because everybody wants a cure, and we hope you'll win a Nobel Prize someday, because you'll have cured lung cancer. But as far as some people needing infused therapies, and there's one gentleman wrote in, he has actually had some complications with his lung cancer, and there are certain devices he has that have to be checked. Periodically he has to go to the hospital. So that's worrisome for people. They want to do telemedicine as much as they can, but they may be in the middle of infusions or some sort of devices that are being checked. How can they be protected? You mentioned about masks, what else?
No, it's a great question. As much as possible, we want to shift to telemedicine and having things done close to the patient's home, but everyone who's fought with cancer on both sides knows that this is something that requires care within the health system, often IV infusions. You mentioned machines that have to be titrated within the health system. For those patients, while one of the good things is that with social distancing and trying to defer truly elective procedures that don't relate to cancer, there are resources at most health systems at the current time.
New York is in a unique scenario, and there are definitely some other hospitals that are in unique scenarios, but everything else is open as normal. And there are checkpoints. So, for example, in our institution before you come in at any door, you're screened, you get questions about fever, travel, breathing symptoms. You have a mask placed on if you're immunocompromised, right? Which most cancer patients are, and you're placed in as safe an environment as possible, probably safer than you could be at the grocery store or things like that just because of the rigorous level of screening that's happening when you come here.
And so, I think one of the key points to make is that if you have something that you need from the health system, these health systems whether it's UCSD or others, are able to provide those in a very safe way—and frankly, in a way that makes me feel as safe within these walls I'm currently here at work than I am really even at home or at the grocery store. And so rest assured that if you need something, we're still here for you. Cancer's not taking a timeout. We can't either. And we'll get it done, and we'll get it done in arguably the safest way possible.
Okay. So, Dr. Patel, you mentioned about different medicines people may be taking. So there are some powerful oral medicines across cancer and in lung cancer. Now, is there a reason for people to stop their medicine, have dosages reduced simply because of the virus and their immune system?
It's a great question. I think for those patients on oral targeted therapies, there's no known data to suggest there's any interaction with the COVID-19 pandemic or the virus or enhanced risk of either contracting it or having severe symptoms from it from taking these medicines, whether it be targeted therapies, immunotherapies. I think with chemotherapy, especially for some of the chemotherapy regimens, that can result in reductions in the white blood cell count, for example, neutrophils in particular and lymphocytes, which are key in fighting infection. There is a theoretical risk, and it's worth a discussion with your doctor if chemotherapy, there may need to be some adjustments there.
Immunotherapy, in fact, is the exact opposite. It activates the immune system. But one of the questions with COVID-19 is, "Is the effect of COVID directly from the virus or mainly from a hyperactive immune response?" And so in its totality, we don't have a lot of answers about how to alter therapy with COVID-19. And so the vast majority of patients it would continue as is given that their cancer treatment likely is at a place that it can't be delayed.
Now for those patients who may have a window for delays, for example, a couple months after they have surgery, potentially before starting adjuvant therapy, maybe a couple weeks after they complete chemo radiation for stage III non-small cell lung cancer before they can continue with immunotherapy. That may be a window to take a break, but the idea that I'm not necessarily convinced that dose adjustments preventatively in the COVID-19 era will necessarily have benefit is one thing I really believe in. In my own practice, we try to continue as is, but we consider, "Hey, if we're going to take a break, maybe this is the time to do it."
Okay. For our audience, if you have a question right now for Dr. Sandip Patel, who is a researcher and a lung specialist at UC San Diego in the Moores Cancer Center there, just hit the Q&A button, and that'll go to our producers, and we'll ask your question. Here's one that came in, and that is related to someone who besides their lung cancer history and treatment is on a blood thinner. So people may be on other medicines like that. Is there anything where blood thinners cause more complications?
Yeah, it's a great point, and actually if you go to the CDC guidance, they say patients with clotting disorders or on blood thinners—and to be honest, I actually looked this up myself ,and I couldn't find anything about blood thinners, whether it's warfarin (Coumadin or Jantoven), which is rarely used in cancer patients in the U.S. Enoxaparin (Lovenox), which is more commonly used, or one of the oral blood thinners of which there are at least three that can be utilized, I'm not aware of any data that suggests that blood thinners represent an enhanced risk.
Now the fact that you're on a blood thinner, especially if it's for a clot in the lung, the risk factor in terms of COVID-19 may be the fact that you have a blood clot in the lungs, what we call a pulmonary embolism. But I wouldn't do anything in terms of decreasing or stopping the dose of the blood thinner, because at least my knowledge and everything I looked up, there's not an interaction in terms of an increasing risk to COVID-19. If anything, by keeping the blood flow from resulting in clots, you're less likely to have respiratory issues that may set you up for worse COVID-19 either exposure or treatment course. And so I think continuing as is on these lifesaving medicines makes a lot of sense here, and in addition to blood thinners.
Okay. You're involved in research, and we've been talking about medicines for lung cancer, now just blood thinners as well. A number of the pharma companies have been applying to the FDA, to have their cancer medicine in trials to see if it can either go to work on the virus or go to work on the cytokine storm that can lead to death related to a COVID-19. So are there lung cancer medicines that you've heard about or medicines that may enter into trials like that? I know in some other areas, but I didn't know about lung cancer.
Yeah, it's a great question. So for the lung cancer medicines more broadly, to my knowledge none of them are being tested for an anti-COVID-type effect. The drugs you're referring to for anti-COVID effect, for example, the IL-6 blocking antibodies, those are anti-inflammatory antibodies that for a rare type of blood disorder are utilized as treatment and may be repurposed for COVID-19. There are some antiviral drugs that are being investigated. And then as many people have heard, there are some rheumatoid arthritis drugs or malaria preventative medicines that are being explored as well.
And so as far as bona fide either cancer immunotherapy, cancer-targeted therapy, chemotherapy, I've not seen any of those being looked at in terms of repurposing for lung cancer. The flip side being drugs that are currently being evaluated by the FDA for treatment of cancer, including lung cancer are continuing to be evaluated. And so the FDA is open even while they're dealing with COVID-19 for continued approval of medicines through the mechanisms that exist for treatment of lung cancer. And so the show must go on from that standpoint. And the FDA should be commended for continuing to approve drugs that are cancer-related in this very difficult time.
So with so many of us where our life as a cancer patient is sort of full stop outside the home anyway, what you're saying is lung cancer research worldwide and here with the FDA working in collaboration with you, that's still happening.
Okay. All right, so now here we are in lung cancer and wondering, okay, so we're going to have telemedicine, trials, there may be accommodations for that. There's no reason necessarily to change our medicines or even stop infusions. That's an individual discussion though with you, our provider. How would you describe the concern for our lung cancer audience now in this time? How should we carry on?
It's a great question. I think in many ways what everyone is doing regardless of if they have cancer or not, it is key for lung cancer patients maybe even more so, because they're fighting cancer, and it's a cancer that's fighting the organ that SARS-CoV-2 or COVID-19 it would actually potentially infect. And so the idea that social distancing makes a lot of sense and actually probably provides an extra benefit to patients with lung cancer, appropriate masking, wearing a bandana, homemade masks, things like that. And then I think the other point to make is some of our patients with lung cancer have a history of smoking, maybe vaping. Those are potential insults, injuries to the lung that if we're going to get COVID-19, it probably is going to be a problem. And so if you've smoked before or you vape, this is as good a time as any to quit, because we want to keep our lungs in as good a shape as possible going into what we're having to deal with.
Okay. Now you're here in California, I am too just up the road from you. So we've been working hard where now if you go into a supermarket, everybody who works there is required to wear a mask I believe. And most people who are going into the supermarket are wearing a mask. And we're told generally and in some cities like LA, if you go out at all, you should wear a mask. So do you feel that, that's making a difference?
Absolutely. I think if you look at the doubling time, which is the number of days it takes for the number of people who are exposed to COVID-19, the places, the states that have incorporated social distancing early have doubling times of five or six days, as you mentioned some cities in California. The places that didn't early on, we've seen this unfortunately in Louisiana, for example, the doubling time initially was between two and three days. And one of the things we have to think about, and I think cancer patients understand this very acutely is exponential growth, right? Cancer likes to have exponential growth, so do viruses. The difference here is anything you do has an exponential benefit, right? So by socially distancing and especially doing it early on, wearing masks, things like that, there's an exponential benefit to everyone you interact with.
And so I think one of the best things we could do, even if you're in a state that hasn't adopted social distancing, though at this point most states have and most jurisdictions have, is practice it for yourself and your loved ones. Because at least you keep your cluster as safe as possible. And a lot of what we do is social, right? When someone has the latest gadget, right, or the latest car, everyone kind of looks and thinks about that. Well, social distancing is similar in the sense that "Hey, if I'm practicing social distancing, I'm wearing a mask in my community, other people have the license to do that too, and we all protect each other."
The other point to make is there are vaccines that many of our cancer patients, including lung cancer patients take routinely. For example, influenza, pneumococcal vaccinations, things of that nature, I think those are crucially important right now for many reasons. One reason being, sometimes when you have an injury to the lung from influenza, you may be more likely to get what's called a super infection from COVID-19 or even a bacterial infection. So taking the vaccines that ideally hopefully people have already, but if they haven't, they should to protect them from other viruses, protect them from COVID-19, even though we don't have a vaccine for that just yet.
Okay. As a researcher, you're into data. Are you with other lung cancer specialists around the world talking to one another now and trying to document the virus related to lung cancer patients to learn more about its effect on people who are in treatment or have been treated for lung cancer?
Absolutely. And I think one of the things that's key in this, and I mentioned earlier how we're all in this together, right? Sharing ventilators, sharing knowledge, is this key aspect in that in a very compressed amount of time we need to learn a lot. And we need to have accurate good information, so we can take care of our patients. And so, one of the key things we're doing with a lot of our collaborators is trying to better understand cancer outcomes, how we can better patients with COVID-19, because I think one of the key points to make about this is we're talking about this initial first surge, right?
What's happening right now—and probably through May—is this initial COVID-19 surge. And getting the technologies, the social distancing, the systems in place, because what's going to happen is we're probably going to have small bumps and peaks throughout the next several months is key, because this is the toughest part of the marathon. It's the incline, right? That we're climbing uphill all April and May, but we still have to run the rest of the marathon in terms of COVID-19, and also fighting cancer simultaneously, and we can do both. But having those systems there, having that knowledge base there, what's successfully preventative and what is a waste of patient's time and money and resources I think is something we need to deliver on. It's something we're actively looking at along with many institutions nationally.
All right, let's talk about the future a little bit. So we know that cancer patients, and certainly lung cancer patients can be immunocompromised. Could be from radiation, could be from chemo, and also they've had as you said, an insult to their lungs where the virus goes. Particularly as the after effect of radiation, let's say, let's just take that as an example. How long does that continue? So let's say that for many people, the super threat subsides or at least subsides for a while and people that have been in their home, they say, "Well, I'm a lung cancer patient. Do I still have to be afraid to go out? Am I still at risk more than other people?" Do you have any crystal ball to say when we can get out more, if you will?
Yeah, it's a great question. I don't know if there's a time you can put on your calendar, right? That we can say, go outside, don't worry about anything, I think it's going to be something we have to re-evaluate over time. I think there are a couple things that'll really move the needle. There are some blood tests coming out that let us in a couple of minutes determine if patients had antibodies against COVID-19. And if you've developed antibodies to COVID-19 because many of the people exposed may be asymptomatic, you're protected from COVID-19 in the same way that if you got a tetanus vaccine, you're as protected as you're going to be. And so once these tests are more widely available, it really informs us that "Hey, listen, no one's 100 percent safe, but you're as safe as anybody else."
The equivalent of you're driving a car with a seatbelt and with all the air bags working, right? That kind of thing. Now for patients who may not have the antibodies available, I think that's really where we need to have these discussions. And those that are otherwise healthy and not in high-risk groups, they may choose to have things go back to normal. But those that are fighting cancer, maybe have lung disease, maybe are otherwise immunocompromised, elderly, things of that nature, if you have those risk factors, we may have to have a discussion on what makes sense.
And that's a good discussion to have with your doctor. We spend a lot of time talking about personalized medicine or precision medicine. And that's not just a fancy DNA test, right? It's creating a whole treatment plan that's unique to the individual for that time. And we're in the era of COVID-19, and we will be even when we get over this initial hump. And so creating a structure, a plan that patients can use, something that they should talk with their cancer doctors about, but I think for long and short it's an individualized decision, it's an individualized time frame. I don't think it's X days after your last radiation or Y days after your last chemo. But I do think this blood test that's coming, that's already being deployed, that tells you if you have antibodies to COVID-19 is really kind of that badge of honor, that passport that you could worry less about this and that that's what's going to lead us to have some sense of normalcy again.
Okay. So we're playing catch-up in the U.S. related to testing and just a lot of different things, social distancing, et cetera. And we're hopefully starting to make some progress on that. Should someone who's a cancer patient and maybe specifically a lung cancer patient, as tests become more available generally be at the head of the line to be tested or their family members who may live with them, right? And then also we have a ways to go, but when there's a vaccine, and that's going to have to roll out too, should we as cancer patients be at the head of the line?
I think so. My expectation would be that the initial patients, once the vaccine is shown to be safe and effective will be high-risk patients, right? So everything we talked about earlier, hypertension, diabetes, cancer, pre-existing lung disease, that makes someone more susceptible to COVID-19 means they actually will be the first to get vaccinated, right? Especially as it first comes out would be my expectation. I think then in terms of more broadly, care of these patients, I think testing for us, for example, at our institution we now can do thousands of tests, where we could only do hundreds before. And initially when we're restricted to those components, it really was patients who had fever, cough, but also had high-risk factors, cancer, diabetes, high blood pressure. Now we can test more broadly, which is great, but it's a double-edged sword, right?
The very thing that makes certain susceptible patient populations, right? Those risk factors like high blood pressure, cancer, diabetes, immunosuppression and age that make people high-risk are part of the reasons those are patients who will get initial testing both for if they get a fever and cough for COVID-19 by PCR to see if they have an active infection right now. But likely these will be the patients that we along with healthcare workers initially want to test if they have immunity, because we need to figure out if they're safe to have kind of go back to regularly scheduled programming so to speak, or need to continue with the current program. And I imagine the vaccine will be treated similarly.
Okay. We're just going to go on a couple more minutes. If our audience has a question, just hit that Q&A button. It goes to my partner Esther Schorr, who's our producer for this program, and then she'll forward it to me. Can you explain one thing that we've been trying to understand related to immunity? There's something called herd immunity, and I'm not sure we understand that. How could that benefit let's say somebody who's immunocompromised or not perfect, where other people even have the antibodies have become immune, could you explain that?
So great question. So herd immunity is a concept for a population, a group of people, that if enough people have been exposed to the virus that now they have immunity to it, they will be much less likely to both shed the virus to other people or whatever the infectious agent is, as well as themselves have issues with that going forward. And so there were actually a couple countries that didn't do social distancing and decided we're just going to try to get herd immunity as fast as possible. But when you do that, if a certain percentage of people get really, really sick and your health system—and this actually happened in the Netherlands, gets overwhelmed, it becomes a big problem. So one of the key points about social distancing you guys may have heard about is what's call flattening the curve. Meaning by having people exposed on different days, it means there are more resources available.
The other way of saying it is, what if every patient with cancer had to get their treatment in one hour on one day? It would overwhelm the entire system, right? Instead, what happens is some patients get their treatment and their visits on Mondays, some get them on Tuesdays, some get them on Wednesday, so on and so forth. And you load balance, right? It's like if every car hit the road at the exact same time, right? And so what social distancing does is it load balances that. And so herd immunity, one of the nice things about herd immunity and the blood tests that checks for antibodies to COVID-19 let you really figure out who has herd immunity or not, is that once enough people have immunity, the chance of them spreading it goes to zero. And it forms an effective bubble around everyone else who may not have herd immunity.
Meaning if you have a hundred people, and 99 people have herd immunity and the last one doesn't, well that one other person doesn't really have COVID-19 to cap anyone out of the catch from those other 99 people, right? Or if you have two people and 98 who don't, you're basically relying on those two people interacting while everyone else is kind of a buffer. And so the key about herd immunity is we all want to get it, but we don't want to all get it at the same time, because some fraction of us may get really sick and overwhelm the freeway, overwhelm the health system.
Okay. We've covered a lot of ground. So just to sum up, Dr. Patel, first of all, thank you for being with us. So lung cancer research proceeds. You're working on procedures that can accommodate people's travel issues and things like that now. That lung cancer patients you do feel have risks that we have to COVID that we have to pay attention to. That you don't believe that rationing of resources will put lung cancer patients at a disadvantage, particularly if they've been doing well on some of these therapies, right? They're not going to be dinged for being a lung cancer patient. And that the progress continues, and you're hopeful about treatments, right? In other words, there's a lot of drug development going on right now tackling this, correct?
Absolutely. And there are a lot of resources going into this. Our engineers here at UCSD have been working on 3D printing masks and working on taking ventilators—I'm sorry, sleep apnea machines and BiPAP machines and converting them to ventilators. Currently one of the crises is that there are not a lot of people flying. So there are a lot of planes, airplanes that are just on the ground. Well, everyone remembers the part of the security actually when you're boarding, they go through kind of their security checklist and they also talk about the oxygen mask dropping. Well, that's actually a potential way of delivering oxygen. So now some of these grounded planes are being co-opted to provide oxygen, right? Ventilatory support in areas that are surging. The American people just need to be told honestly what's going on.
And then we as a group can with our resilience really just figure out ways of tackling this as a broader society. And so I think one of the key messages I really want to relay to our lung cancer community, but also just the cancer community more broadly is that we got into COVID-19 because we're linked together. We'll get out of this because we are linked together. And we'll figure out exotic ways of making sure that people don't have to worry about lines for ventilators.
We're ramping up production of masks and things like that. And I really think there's really been no challenge the American people haven't been able to handle when we've joined together. And we're seeing that. There are ventilators that are coming from Washington, California to New York. When New York's done, I know they're going to send it forward to whoever else needs it and pay it forward. And so we're going to get through this together. It's a tough time, but I want patients to know that we're all still here in the healthcare industry, taking care of you guys. And our goal is to make sure you guys are safe, both with your cancer but also during this COVID-19 pandemic. And we're there for you.
Well, I want to thank you so much, Dr. Patel. Here in Carlsbad up the road from you where you're in the La Jolla area, you probably can't hear us, but we've started doing something at 8 PM every night like they were doing in Colorado and almost imitating what they'd been doing where they applaud healthcare providers at 8 PM every night. We've been howling at the moon. But it's really to honor healthcare providers. So our neighbors, we roll open the windows, we howl for 30 seconds. But it's really a tribute to you guys and what you're doing for us. So first of all, on the research side, thank you for moving it forward, because certainly in lung cancer it's helped people so much already, and will continue to and maybe even lead to cures. And thank you for your devotion for people for the treatment of lung cancer.
And also you work at UCSD more generally in clinical trials and in cancer treatment at the Moores Cancer Center. Dr Sandip Patel, thank you so much for being with us today. We really appreciate it.
Thank you for having me.
Okay. I'm Andrew Schorr, we'll continue to do our series on a variety of cancers and take a look at an earlier one on our webpage with Dr. Ross Camidge, who Dr. Patel knows, who's a leading lung cancer specialist. And we have others coming up. And then more broadly about living with cancer and things in relationship with your doctor, like telehealth that Dr. Patel mentioned. How do you use that successfully with your doctor to have confidence that you're getting good care? Okay, Dr. Patel, thanks so much. I'm Andrew Schorr up the road from him in San Diego County. Remember, knowledge can be the best medicine of all.
Why Should Lung Cancer Patients Consider a Clinical Trial?
Testing for Coronavirus: The Who, What and Where
Debunking Coronavirus Myths
Save your favorite articles
In order to save an article you must be signed in as a member.
Sign up now to save articles, get E-News, become a part of the Patient Power family, and take control of your health.
Added "Lung Cancer" to your saved articles
You can view and edit this list in your account.
View Saved ArticlesContinue reading


A fire boss has stressed the importance of smoke alarms after firefighters tackled a kitchen blaze in Blackpool today.
Fire crews from Blackpool and South Shore attended the incident on Dean Street at around 11.30am.
The emergency call was made by the occupier of the property.
Watch manager Steve Boyne, of South Shore fire station explained; "We attended to quite a serious kitchen fire which was well alight.
"Everybody was out of the building fortunately, but it suffered extensive damage to the kitchen."
Firefighters used tow breathing apparatus, a hose reel and a ventilation unit.
Mr Boyne said there were no smoke alarms fitted or working in the property.
"We can't stress enough they save more lives than we do." he said.
"Keep them fitted, tested and working."


text:
Henrik Åström is an award-winning composer born in Gothenburg, Sweden, in 1980. During his childhood he travelled a great deal, accompanying his father who was an archaeologist on digs in strange parts of the world. Every summer, he sat in soil and dust, under Greece's scorching sun, with a shovel in his hand – without quite knowing what he was looking for.
It was much later that he realized that all this had become a part of his heart. Three thousand year old jars had spoken to him. It was the first time he had seen the world with curious eyes. He had wanted to understand it, explore it, and to show others what he had found. But he had not chosen to follow in his father's footsteps.
At age eight, he discovered the piano. Like an archaeological dig, he wanted to dive into its depths and look for sounds that could explain everything – even life itself. He began his musical search and studied at the Stockholm Music Conservatory and later at Berklee College of Music in Boston. Between 2002 and 2012 he ran the recording studio A-Stream Studio in Stockholm where he worked with grammy-winning artists such as Miss Li, Titiyo, and Glen Matlock from the legendary band Sex Pistols. Besides his work as a music producer, he wrote experimental dance/theatre music for the acclaimed dancer and choreographer Frauke, the First Physical Theatre Company in South Africa, Los Angeles Movement Arts and Mandarin Orange Performing Arts in New York.
After relocating to the US, Åström has composed original film scores for a great number of filmmakers, including acclaimed directors Dan Zukovic (director of the cult classic 'The Last Big Thing' starring Mark Ruffalo), Ian McCrudden (grammy award nominated for 'Anita O' Day – The Life of A Jazz Singer') and Alison Parker (Dude, Where's My Ferret?, for which Åström won a Goldie Award for Best Musical Score in 2016).
Åström has scored the TV series Secrets of the Viking Stone for Discovery/Science Channel, written additional music for the popular Dishonored video game franchise with composer Daniel Licht, and worked with composer Heitor Pereira on the animated blockbuster film Angry Birds. Current projects include Internment, an Albanian/American period piece drama, the upcoming feature film Eyes Upon Waking directed by Jennifer Scott (Hitch, 30 Rock), and the upcoming action/drama Mango Bajito starring Danny Trejo (Heat, Sons of Anarchy).
Most recently Åström wrote additional music for seven episodes of the CBS All Access Limited Series The Stand, based on the novel by Stephen King and starring James Marsden and Whoopi Goldberg.
He currently resides and has his studio in Beverly Hills, Los Angeles.
Client remarks
After an extensive search for a music composer for our feature film, we discovered Henrik, whose extraordinary talent is contributing immeasurably to our project.
– Juan Castillo, dir. Mango Bajito
Really great stuff–the mix of horror and spaghetti western vibe is a very compelling combination, hilarious and spot on. Really exceptional.
– Dan Zukovic, actor/director, Scammerhead
Can't thank you enough for the wonderful work. Love your music and really love how it emboldens the emotion of the film. Rare collaboration I treasure. To more!
– Ian McCrudden, dir. Child of Grace


One of the most common causes of a slow scan relates to a large response time between the scanner and the target website or web application. The average response time is an average of the total time between the sending of the request made by the scanner and the web server's response.
An average response time of 200ms (0.2 of a second) or less should be considered to be a good response time, while a response time over 300ms (0.3 a second) is considered to be prohibitively large, and therefore, scans may take very long to complete.
For example, if we take a scan with an average response time of 200ms which is the optimal average response time and another scan with an average response time of 400ms which is considered as a large response time, double that which is regarded as optimal.
For example, if a scan takes 30 minutes to complete with an average response time of 200ms, if the same scan had an average response time of 400ms, the scan would take 1 hour to complete.
Unfortunately, there is no one factor that may be causing a high response time. The following are some issues to look into when the server's response time is too high.
Check factors such as CPU, memory, hard disk access and other resources. Most often, a simple server upgrade may solve the problem.
Once again, check CPU, memory and hard disk access in relation to the resources being used by the database. Additionally check if any queries are taking too long to execute and if these can be optimized.
Ideally, perform this test from different locations so as to confirm whether the server's network is the bottleneck.
Check if any of these systems are being used and if they are contributing to the high increase of your average response time. This may be the case since every incoming request on your web server will be thoroughly analysed thus increasing the response time.
It might be ideal that the machine you are running Acunetix on be whitelisted for any of these security mechanisms, so that requests and responses pass through unhindered.
There may be situations when improving the response time is not possible (at least not immediately). In such cases, you have the following options.
There are situations where you only need to scan part of the website, in which case, you can exclude some pages or full directories from the scan. Once the scan is run, these paths are automatically not crawled. For more information, please refer to the Path Exclusions guide.
You may also consider using Scan Types, which will run a more specific set of scripts that aim to find a narrower group of vulnerabilities. Once such example is, if you first want to find the most important to fix and high risk vulnerabilities for a start, you may choose the High Risk Vulnerabilities Scan Type. For more information, please refer to the Scan Types guide.
The Scan Speed is set to Fast by default, but you may find that this configuration might not suite your needs. There are some cases where the Scan Speed should be put on a slower setting. This might seem counter intuitive for shortening scan times, although a fast scan will be sending multiple concurrent requests to the web server. This could congest your web server with requests, thus taking a long time to send back a response. A slower scan speed might mitigate this if your web server cannot keep up with the amount of requests being sent by Acunetix. On the other hand, if your web server is able to easily handle multiple requests at the same time, make sure that you are using the Fast Scan Speed setting.
In the case of very large or complex web applications (thousands of directories and files or thousands of inputs) the scanner will take longer to perform such scans since it needs to analyse a lot more information than if there were less pages and inputs. To such an extent, it is recommended to split large websites or web applications across several Targets and Scans.
None of the settings you mention appear to be available in OVS. How can I scan just one directory with OVS?
This post is related to Acunetix Web Vulnerability Scanner (the on-premise version). Acunetix Online does not allow granular control of the scan.
Please ensure that you are using the latest version, as we have addressed a lot of such issues in the most recent versions.
Should the problem persist, please contact our support team who can troubleshoot the specific circumstances leading to the crash.


text:
TẠI SAO CẦN XỬ LÝ NƯỚC CHO LÒ HƠI ?
Nội dung đang cập nhật...aIt may not sound like a lot, but if you estimate the manpower, working hours, materials, planning and correlating that were all involved in completing each separate project, then our productivity is immense! Since then we've built hundreds of commercial, government and private buildings and facilities.
Our construction company has been founded 10 years ago, at the very peak of the building frenzy in the Viet Nam…
Since then we've built hundreds of commercial, government and private buildings and facilities. It may not sound like a lot, but if you estimate the manpower, working hours, materials, planning and correlating that were all involved in completing each separate project, then our productivity is immense!
It may not sound like a lot, but if you estimate the manpower, working hours, materials, planning and correlating that were all involved in completing each separate project, then our productivity is immense! Since then we've built hundreds of commercial, government and private buildings and facilities.


text:
Maktabat MEPI Library
Training Resources for Civil Society in the Middle East and North Africa
Instagram Twitter Facebook MEPI MEPI
Submit Training Resources
Initial Search: (502)
Technical Areas: Civic Engagement
Previous: (6)
Organizations: Foundation for the Defense of Democracies (FDD)/Center for Liberty in the Middle East (CLIME)
Current: (6)
Target Groups: CSOs/NGOs
Assessing Your Political Environment
Organization: Foundation for the Defense of Democracies (FDD)/Center for Liberty in the Middle East (CLIME)
Project: Online Activism Institute
This self-paced course guides users in analyzing their country's political environment and exploring ways in which it could affect the implementation of activism plans. It includes six lessons, focusing on the political environment, branches of government, civic freedoms and the role of civil society.
Create Your Activism Plan
This self-paced course helps users to understand what they need to do to accomplish their goals. It presents a guide for creating a specific plan to succeed. The course covers six "building blocks" of activism: vision, goals and objectives, leadership, civic environment, message and audience, and outreach activities.
Create Your Activism Plan Builder Template (Designed to Accompany the rest of the Create Your Activism Plan Course)
The Activism Plan Builder Template includes questions about goals and objectives, leadership, civic environment, message and audience, and outreach activies. Information about the steps is included, as well as templates for developing an activism plan.
In this self-paced course, participants learn how to use the media to communicate their messages to constituencies. Media techniques are described, including how to present messages online. Also included is information about how to organize media briefings and materials to keep the media informed of plans, events and accomplishments.
Develop Your Personal Leadership Style
In this self-paced course, users explore and develop their leadership style and identify what kind of leadership would be most effective for their situation. Steps are included to create a plan for developing a communication style.
Polish Your Public Speaking Skills
This self-paced public speaking course was designed primarily for women running for public office in the Arab world. It describes how to craft and deliver a message that is memorable. The aim is for participants to become more confident, prepared and in-demand speakers.
About MEPI
Total Returned (6)
Civic Engagement (6)
Gender and Youth (6)
CSOs/NGOs (6)
Marketing/Branding (1)
Media Outreach (1)
Foundation for the Defense of Democracies (FDD)/Center for Liberty in the Middle East (CLIME)
Online Activism Institute
Instructor Curriculum
The Maktabat MEPI Library is a regularly updated online repository for training resources developed by civil society organizations and institutions that support civil society in the Middle East and North Africa (MENA) region through funding from The U.S.-Middle East Partnership Initiative (MEPI).
Email: contact@maktabatmepi.org
2017 © All Rights Reserved | Terms of Use


text:
500 када је југословенски телевизијски филм из 1981. године. Режирао га је Милан Јелић, а сценарио је писао Гордан Михић.

Радња

На стовариште једног предузећа, неко је донео и оставио 500 када за купање, за које нико не зна чије су, коме су намењене и шта са њима треба чинити. Заседа раднички савет у присуству инспектора.

Улоге

|-
|Никола Симић || Тржишни инспектор
|-
|Властимир Ђуза Стојиљковић || Стојко Стојковић
|-
|Ружица Сокић || председница радничке контроле
|-
|Оливера Марковић || Јела чистачица
|-
|Милан Гутовић || Цојко
|-
|Ђорђе Јелисић ||
|-
|Предраг Лаковић || Милун Шековић
|-
|Драгољуб Милосављевић || Портир
|-
|Миленко Павлов || Син портира
|-
|Бранко Петковић || Конобар
|-
|Ђорђе Пура || Ватрогасац
|-
|Жарко Радић ||
|}

Спољашње везе

Југословенски филмови
Српски филмови
Филмови 1981.
Телевизијски филмови
Српски телевизијски филмови
Српске телевизијске комедије
Филмске комедије


text:
<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE sqlMap PUBLIC "-//iBATIS.com//DTD SQL Map 2.0//EN" "http://www.ibatis.com/dtd/sql-map-2.dtd">

<sqlMap namespace="Security">

	<typeAlias alias="Account" type="net.herit.security.dto.Account" />
	<typeAlias alias="Group" type="net.herit.security.dto.Group" />
	<typeAlias alias="GroupAuthorization" type="net.herit.security.dto.GroupAuthorization" />
	<typeAlias alias="URIResource" type="net.herit.security.dto.URIResource" />

	<resultMap id="authenticationInfo" class="Account">
		<result property="accountId" column="ID" />
		<result property="groupId" column="MNG_ACCOUNT_GROUP_ID" />
		<result property="name" column="NAME" />
		<result property="loginId" column="LOGIN_ID" />
		<result property="loginPassword" column="LOGIN_PASSWORD" />
		<result property="createTime" column="CREATE_TIME" />
		<result property="updateTime" column="UPDATE_TIME" />
		<result property="lastAccessTime" column="LAST_ACCESS_TIME" />
		<result property="email" column="EMAIL" />
		<result property="phone" column="PHONE" />
		<result property="mobile" column="MOBILE" />
		<result property="department" column="DEPARTMENT" />
		<result property="disabled" column="DISABLED" />
		<result property="failCount" column="FAIL_COUNT" />
	</resultMap>

	<resultMap id="groupAuthorizationList" class="GroupAuthorization">
		<result property="groupId" column="MNG_ACCOUNT_GROUP_ID" />
		<result property="resource" column="RESOURCE" />
		<result property="authorizationDBCreate" column="RIGHT_C" />
		<result property="authorizationDBRead" column="RIGHT_R" />
		<result property="authorizationDBUpdate" column="RIGHT_U" />
		<result property="authorizationDBDelete" column="RIGHT_D" />
	</resultMap>

	<resultMap id="uriResourceList" class="URIResource">
		<result property="uriResourceId" column="ID" />
		<result property="uri" column="URI" />
		<result property="description" column="DESCRIPTION" />
		<result property="isExcludeAuthentication" column="AUTH_CHECK" />
	</resultMap>

	<select id="SecurityDAO.getAccount" parameterClass="Account" resultMap="authenticationInfo">
		<![CDATA[
			SELECT
				ID,
				MNG_ACCOUNT_GROUP_ID,
				NAME,
				LOGIN_ID,
				LOGIN_PWD AS LOGIN_PASSWORD,
				DATE_FORMAT(CREATE_TIME, '%Y%m%d%H%i%s') AS CREATE_TIME,
				DATE_FORMAT(UPDATE_TIME, '%Y%m%d%H%i%s') AS UPDATE_TIME,
				DATE_FORMAT(LAST_ACCESS_TIME, '%Y%m%d%H%i%s') AS LAST_ACCESS_TIME,
				EMAIL,
				PHONE,
				MOBILE,
				DEPARTMENT,
				DISABLED,
				FAIL_COUNT
			FROM
				MNG_ACCOUNT
			WHERE
				LOGIN_ID = #loginId#
		]]>
	</select>

	<select id="SecurityDAO.getGroupAuthorizationList" parameterClass="java.lang.Integer" resultMap="groupAuthorizationList">
		<![CDATA[
			SELECT
				A.MNG_ACCOUNT_GROUP_ID,
				(SELECT T.URL_PATH FROM MNG_MENU_MASTER T WHERE T.MENU_ID = A.MENU_ID) AS RESOURCE,
				RIGHT_C,
				RIGHT_R,
				RIGHT_U,
				RIGHT_D
			FROM
				MNG_GROUP_RIGHT  A
			WHERE
				A.MNG_ACCOUNT_GROUP_ID = #groupId#
		]]>
	</select>

	<select id="SecurityDAO.getURIResourceList" resultMap="uriResourceList">
		<![CDATA[
			SELECT
				ID,
				URI,
				DESCRIPTION,
				AUTH_CHECK
			FROM
				MNG_URI_RESOURCE
		]]>
	</select>

	<select id="SecurityDAO.getIpLimitCount" resultClass="int">
		SELECT
			 COUNT(*)
		FROM
			MNG_IP_LIMIT
		WHERE 1=1
			AND LOGIN_ID = #loginId#
    </select>

	<select id="SecurityDAO.isAvailableIpLimitCheck" resultClass="int">
		SELECT
			 COUNT(*)
		FROM
			MNG_IP_LIMIT
		WHERE 1=1
			AND LOGIN_ID = #loginId#
			AND IP = #ip#
    </select>

	<update id="SecurityDAO.updateLoginFailCount">
		UPDATE MNG_ACCOUNT SET
			 FAIL_COUNT = FAIL_COUNT + 1
		WHERE 1=1
			AND LOGIN_ID = #loginId#
	</update>
	<update id="SecurityDAO.updateLoginFailCountReset">
		UPDATE MNG_ACCOUNT SET
			 FAIL_COUNT = 0
		WHERE 1=1
			AND LOGIN_ID = #loginId#
	</update>

</sqlMap>

redpajama_set_name: RedPajamaGithub


text:
/ IRL
Jack in the Box Acquiring Del Taco
By Nicole Drum - December 6, 2021 07:39 pm EST
Jack in the Box is buying Del Taco, the second-largest Mexican quick-serve restaurant in the United States, for $575 million. The deal was announced on Monday. Together, the two restaurants will have more than 2800 locations across 25 states and the deal is expected to allow Jack in the Box to tap into the growing Mexican food category while also create substantial opportunities for franchisee expansion across both brands.
Del Taco was founded in 1964 and serves more than three million guests each week across its approximately 600 locations in 16 states. Jack in the Box is a San Diego-based company and one of the nation's largest hamburger chains with more than 2200 restaurants in 21 states and Guam. The deal between Del Taco and Jack in the Box will include existing debt, per the company's press release.
"We are thrilled to welcome Del Taco, a beloved brand and proven regional winner, to the Jack in the Box family," Darin Harris, CEO of Jack in the Box said in a statement. "This is a natural combination of two like-minded, challenger brands with outstanding growth opportunities. Together, Jack in the Box and Del Taco will benefit from a stronger financial model, gaining greater scale to invest in digital and technology capabilities, and unit growth for both brands. This acquisition fits squarely in our strategic pillars and helps us create new opportunities for the franchisees, team members and guests of both brands."
He continued, "Del Taco has a loyal, passionate guest base and a strong operating model, and we believe that we can leverage our infrastructure, experience refranchising, and development strategy to support Del Taco's growth plans and expand Del Taco's footprint. We can't wait to welcome the Del Taco team members and franchisees to the Jack family!"
"We are excited to have found a partner in Jack in the Box that shares our vision for the future and has the QSR expertise to further accelerate Del Taco's growth," John D. Cappasola, Jr. President and CEO of Del Taco said. "In recent years, we have uniquely positioned Del Taco as a leader in the growing Mexican QSR category, expanded our digital capabilities to enhance consumer convenience and focused on growing the brand through franchising, resulting in eight consecutive years of franchise same store sales growth and an accelerating new unit pipeline."
He added, "We expect this transaction will provide Del Taco with the scale, complementary capabilities and opportunity to become even stronger partners to our franchisees and support their ability to drive substantial growth in our core and emerging markets. On behalf of Del Taco Restaurants, Inc. Board of Directors, we're confident the agreement delivers immediate value to Del Taco shareholders and will greatly benefit our brand, team members, franchisees and loyal guests for many years to come."
This deal between Jack and the Box and Del Taco comes approximately three years after Jack in the Box parted ways with another Mexican fast-casual chain, Qdoba. Jack in the Box had acquired Qdoba in 2003 and sold the brand in 2018.
Photo: Don & Melinda Crawford/Education Images/Universal Images Group via Getty Images
Bob Saget: Hollywood Mourns the Loss of Comedy Legend
Jim Carrey Celebrates 60th Birthday With Fun Video
Ray Fisher Responds to Joss Whedon's Justice League Movie Comments
Watch a Blindfolded Speedrunner Beat Sekiro: Shadows Die Twice in 2 Hours
Lay's Announces Golden Grounds, Chips Made From Potatoes Grown in Soil From NFL Stadiums
Ubisoft Developing VR Escape Game About Notre-Dame Fire
Walmart Is Making Quiet Moves Into the Metaverse
Rumored Uncharted LEGO Set a Hoax


a Bass by Louis Lowendall (1842-1918), Berlin 1910. Fully Restored with C-Extension by AES NY, August 2016.
This is a 7/8ths (or 4/4 size of its time), 'BERLIN' stamped in the upper back button. Beautiful reddish brown varnish (the red well faded), with a grafted neck, original scroll with slight scars from a previous mechanical C-Extension. Wide lower bouts, deep ribs w/outer linings, slightly sloped shoulders and easy to play. Well arched round back tapered and the upper bout ribs taper towards the neck to 6 1/4" wide. Well flamed maple throughout with fine-medium grained spruce top. Deep warm tone with good projecting power.
Ribs (not including plates); 8 5/8", upper bout tapers to 6.25"/Neck.
This looks to be the real deal from its period, a professional orchestra bass. For more information on L. Lowendall and his son Louis Jr., read this article from the 1893 exhibit in Chicago.
Fully Restored with C-Extension by AES NY, August 2016.